The weekly litigation news digest is live. Subscribe now

IP Verse

Rinat Neuroscience competitive analysis

Loading summary...

Latest patents of Rinat Neuroscience opposed by its competitors

Explore Rinat Neuroscience's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2100902
Dec 18, 2019Methods For Treating Pain By Administering An Antagonist Antibody Against The Nerve Growth Factor And An Opioid Analgesic, And Compositions Containing The Same1
EP2206728
Oct 10, 2018Methods For Treating Bone Cancer Pain By Administering A Nerve Growth Factor Antagonistic Antibody1
EP2305711
Aug 2, 2017Methods For Treating Osteoarthitis Pain By Administering A Nerve Growth Factor Antagonist And Compositions Containing The Same2

Latest PTAB cases involving Rinat Neuroscience

Discover the latest PTAB cases involving Rinat Neuroscience, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Rinat Neuroscience with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
RINAT NEUROSCIENCE - 4 - -
REGENERON PHARMACEUTICALS3894931
TEVA PHARMACEUTICALS20916 - 12